{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:03:23Z","timestamp":1790370203789,"version":"4.1.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:00:00Z","timestamp":1599782400000},"content-version":"vor","delay-in-days":1290,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/https:\/\/dx.doi.org\/10.13039\/501100007155","name":"Medical Research Council","doi-asserted-by":"publisher","award":["1529328"],"award-info":[{"award-number":["1529328"]}],"id":[{"id":"10.13039\/https:\/\/dx.doi.org\/10.13039\/501100007155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/https:\/\/dx.doi.org\/10.13039\/501100007903","name":"Bloodwise","doi-asserted-by":"publisher","award":["10012"],"award-info":[{"award-number":["10012"]}],"id":[{"id":"10.13039\/https:\/\/dx.doi.org\/10.13039\/501100007903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/https:\/\/dx.doi.org\/10.13039\/501100007903","name":"Bloodwise","doi-asserted-by":"publisher","award":["12050"],"award-info":[{"award-number":["12050"]}],"id":[{"id":"10.13039\/https:\/\/dx.doi.org\/10.13039\/501100007903","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mcponline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular & Cellular Proteomics"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1074\/mcp.m116.063511","type":"journal-article","created":{"date-parts":[[2017,1,4]],"date-time":"2017-01-04T22:00:26Z","timestamp":1483567226000},"page":"386-406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Integrated Cellular and Plasma Proteomics of Contrasting B-cell Cancers Reveals Common, Unique and Systemic Signatures"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7032-0227","authenticated-orcid":false,"given":"Harvey E.","family":"Johnston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry L.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Dunscombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antigoni","family":"Manousopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Townsend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1050-0805","authenticated-orcid":false,"given":"Spiros D.","family":"Garbis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2077-089X","authenticated-orcid":false,"given":"Mark S.","family":"Cragg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/mcp.M116.063511_bib1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0014-2964(72)90025-4","article-title":"Cell kinetics of African c.ases of Burkitt lymphoma. A preliminary report","volume":"8","author":"Iversen","year":"1972","journal-title":"Eur. J. Cancer"},{"key":"10.1074\/mcp.M116.063511_bib2","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S0140-6736(11)61177-X","article-title":"Burkitt's lymphoma","volume":"379","author":"Molyneux","year":"2012","journal-title":"Lancet"},{"key":"10.1074\/mcp.M116.063511_bib3","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/318533a0","article-title":"The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice","volume":"318","author":"Adams","year":"1985","journal-title":"Nature"},{"key":"10.1074\/mcp.M116.063511_bib4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.semcancer.2006.07.014","article-title":"The c-Myc target gene network","volume":"16","author":"Dang","year":"2006","journal-title":"Semin. Cancer Biol"},{"key":"10.1074\/mcp.M116.063511_bib5","doi-asserted-by":"crossref","first-page":"R69","DOI":"10.1186\/gb-2003-4-10-r69","article-title":"An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets","volume":"4","author":"Zeller","year":"2003","journal-title":"Genome Biol"},{"key":"10.1074\/mcp.M116.063511_bib6","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1126\/science.2251503","article-title":"Sequence-specific DNA binding by the c-Myc protein","volume":"250","author":"Blackwell","year":"1990","journal-title":"Science"},{"key":"10.1074\/mcp.M116.063511_bib7","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1038\/sj.onc.1202746","article-title":"MYC oncogenes and human neoplastic disease","volume":"18","author":"Nesbit","year":"1999","journal-title":"Oncogene"},{"key":"10.1074\/mcp.M116.063511_bib8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1084\/jem.167.2.353","article-title":"The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells","volume":"167","author":"Harris","year":"1988","journal-title":"J. Exp. Med"},{"key":"10.1074\/mcp.M116.063511_bib9","doi-asserted-by":"crossref","first-page":"8525","DOI":"10.1158\/0008-5472.CAN-08-1329","article-title":"Utilization of pathway signatures to reveal distinct types of B lymphoma in the Emicro-myc model and human diffuse large B-cell lymphoma","volume":"68","author":"Mori","year":"2008","journal-title":"Cancer Res"},{"key":"10.1074\/mcp.M116.063511_bib10","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1182\/blood-2004-07-2573","article-title":"Deregulated expression of the Myc cellular oncogene drives development of mouse \u201cBurkitt-like\u201d lymphomas from naive B cells","volume":"105","author":"Zhu","year":"2005","journal-title":"Blood"},{"key":"10.1074\/mcp.M116.063511_bib11","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","article-title":"Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines","volume":"111","author":"Hallek","year":"2008","journal-title":"Blood"},{"key":"10.1074\/mcp.M116.063511_bib12","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","article-title":"Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines","volume":"111","author":"Hallek","year":"2008","journal-title":"Blood"},{"key":"10.1074\/mcp.M116.063511_bib13","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/sj.leu.2404017","article-title":"TCL1 shows a regulated expression pattern in chronic lymphocytic leukemia that correlates with molecular subtypes and proliferative state","volume":"20","author":"Herling","year":"2006","journal-title":"Leukemia"},{"key":"10.1074\/mcp.M116.063511_bib14","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1182\/blood-2004-04-1453","article-title":"Impaired T- and B-cell development in Tcl1-deficient mice","volume":"105","author":"Kang","year":"2005","journal-title":"Blood"},{"key":"10.1074\/mcp.M116.063511_bib15","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/labinvest.3780264","article-title":"TCL1 oncogene expression in B cell subsets from lymphoid hyperplasia and distinct classes of B cell lymphoma","volume":"81","author":"Said","year":"2001","journal-title":"Laboratory Investigation"},{"key":"10.1074\/mcp.M116.063511_bib16","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1073\/pnas.97.7.3028","article-title":"Tcl1 enhances Akt kinase activity and mediates its nuclear translocation","volume":"97","author":"Pekarsky","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1074\/mcp.M116.063511_bib17","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1097-2765(00)00039-3","article-title":"The protooncogene TCL1 is an Akt kinase coactivator","volume":"6","author":"Laine","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1074\/mcp.M116.063511_bib18","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1073\/pnas.102181599","article-title":"Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression","volume":"99","author":"Bichi","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1074\/mcp.M116.063511_bib19","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1182\/blood-2005-12-011213","article-title":"Characterization of the TCL-1 transgenic mouse as a preclinical drug development tool for human chronic lymphocytic leukemia","volume":"108","author":"Johnson","year":"2006","journal-title":"Blood"},{"key":"10.1074\/mcp.M116.063511_bib20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3727\/105221615X14181438356256","article-title":"The long journey of TCL1 transgenic mice: lessons learned in the last 15 years","volume":"16","author":"Pekarsky","year":"2015","journal-title":"Gene Expr"},{"key":"10.1074\/mcp.M116.063511_bib21","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1182\/blood-2014-05-577122","article-title":"Mouse models in the study of chronic lymphocytic leukemia pathogenesis and therapy","volume":"124","author":"Simonetti","year":"2014","journal-title":"Blood"},{"key":"10.1074\/mcp.M116.063511_bib22","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nature13319","article-title":"Mass-spectrometry-based draft of the human proteome","volume":"509","author":"Wilhelm","year":"2014","journal-title":"Nature"},{"key":"10.1074\/mcp.M116.063511_bib23","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nature13302","article-title":"A draft map of the human proteome","volume":"509","author":"Kim","year":"2014","journal-title":"Nature"},{"key":"10.1074\/mcp.M116.063511_bib24","doi-asserted-by":"crossref","first-page":"D959","DOI":"10.1093\/nar\/gkt1251","article-title":"Plasma Proteome Database as a resource for proteomics research: 2014 update","volume":"42","author":"Nanjappa","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1074\/mcp.M116.063511_bib25","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1074\/mcp.M114.046813","article-title":"Multiplexed, quantitative workflow for sensitive biomarker discovery in plasma yields novel candidates for early myocardial injury","volume":"14","author":"Keshishian","year":"2015","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.M116.063511_bib26","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1021\/pr400307u","article-title":"Immunodepletion plasma proteomics by tripleTOF 5600 and Orbitrap elite\/LTQ-Orbitrap Velos\/Q exactive mass spectrometers","volume":"12","author":"Jones","year":"2013","journal-title":"J. Proteome Res"},{"key":"10.1074\/mcp.M116.063511_bib27","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.1021\/pr300686k","article-title":"Assessment of two immunodepletion methods: off-target effects and variations in immunodepletion efficiency may confound plasma proteomics","volume":"11","author":"Patel","year":"2012","journal-title":"J. Proteome Res"},{"key":"10.1074\/mcp.M116.063511_bib28","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.1021\/pr5003406","article-title":"Whole serum 3D LC-nESI-FTMS quantitative proteomics reveals sexual dimorphism in the milieu interieur of overweight and obese adults","volume":"13","author":"Al-Daghri","year":"2014","journal-title":"J. Proteome Res"},{"key":"10.1074\/mcp.M116.063511_bib29","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1021\/ac102075d","volume":"83","author":"Garbis","year":"2011","journal-title":"Anal. Chem"},{"key":"10.1074\/mcp.M116.063511_bib30","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1258\/002367786781062016","article-title":"A better method for terminal bleeding of mice","volume":"20","author":"Adeghe","year":"1986","journal-title":"Lab. Animals"},{"key":"10.1074\/mcp.M116.063511_bib31","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/nmeth.2610","article-title":"DMSO enhances electrospray response, boosting sensitivity of proteomic experiments","volume":"10","author":"Hahne","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1074\/mcp.M116.063511_bib32","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nbt.2839","article-title":"ProteomeXchange provides globally coordinated proteomics data submission and dissemination","volume":"32","author":"Vizcaino","year":"2014","journal-title":"Nat. Biotechnol"},{"key":"10.1074\/mcp.M116.063511_bib33","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1002\/pmic.201100033","article-title":"The role of statistical power analysis in quantitative proteomics","volume":"11","author":"Levin","year":"2011","journal-title":"Proteomics"},{"key":"10.1074\/mcp.M116.063511_bib34","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1182\/blood-2014-11-610329","article-title":"The PI3K\/mTOR inhibitor PF-04691502 induces apoptosis and inhibits microenvironmental signaling in CLL and the Emicro-TCL1 mouse model","volume":"125","author":"Blunt","year":"2015","journal-title":"Blood"},{"key":"10.1074\/mcp.M116.063511_bib35","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1182\/blood-2014-08-593061","article-title":"Upregulation of FcgammaRIIb on monocytes is necessary to promote the superagonist activity of TGN1412","volume":"125","author":"Hussain","year":"2015","journal-title":"Blood"},{"key":"10.1074\/mcp.M116.063511_bib36","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1242\/jcs.00740","article-title":"Endopolyploid cells produced after severe genotoxic damage have the potential to repair DNA double strand breaks","volume":"116","author":"Ivanov","year":"2003","journal-title":"J. Cell Sci"},{"key":"10.1074\/mcp.M116.063511_bib37","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M110.006353","article-title":"A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas","volume":"10","author":"Farrah","year":"2011","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.M116.063511_bib38","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.cell.2012.06.033","article-title":"Tristetraprolin impairs myc-induced lymphoma and abolishes the malignant state","volume":"150","author":"Rounbehler","year":"2012","journal-title":"Cell"},{"key":"10.1074\/mcp.M116.063511_bib39","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1002\/pmic.201000752","article-title":"Minimising iTRAQ ratio compression through understanding LC-MS elution dependence and high-resolution HILIC fractionation","volume":"11","author":"Ow","year":"2011","journal-title":"Proteomics"},{"key":"10.1074\/mcp.M116.063511_bib40","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1074\/mcp.M900628-MCP200","article-title":"Addressing accuracy and precision issues in iTRAQ quantitation","volume":"9","author":"Karp","year":"2010","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.M116.063511_bib41","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.3324\/haematol.2012.065581","article-title":"RHAMM\/HMMR (CD168) is not an ideal target antigen for immunotherapy of acute myeloid leukemia","volume":"97","author":"Snauwaert","year":"2012","journal-title":"Haematologica"},{"key":"10.1074\/mcp.M116.063511_bib42","first-page":"95","article-title":"Expression of RHAMM\/CD168 and other tumor-associated antigens in patients with B-cell chronic lymphocytic leukemia","volume":"29","author":"Giannopoulos","year":"2006","journal-title":"Int. J. Oncol"},{"key":"10.1074\/mcp.M116.063511_bib43","doi-asserted-by":"crossref","first-page":"D447","DOI":"10.1093\/nar\/gku1003","article-title":"STRING v10: protein-protein interaction networks, integrated over the tree of life","volume":"43","author":"Szklarczyk","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1074\/mcp.M116.063511_bib44","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","article-title":"Causal analysis approaches in Ingenuity Pathway Analysis","volume":"30","author":"Kramer","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1074\/mcp.M116.063511_bib45","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1161\/CIRCRESAHA.114.303429","article-title":"Regulation of acetylation of histone deacetylase 2 by p300\/CBP-associated factor\/histone deacetylase 5 in the development of cardiac hypertrophy","volume":"114","author":"Eom","year":"2014","journal-title":"Circ. Res"},{"key":"10.1074\/mcp.M116.063511_bib46","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/dc.22819","article-title":"Molecular genetic characterization of lymphoma: application to cytology diagnosis","volume":"40","author":"Ochs","year":"2012","journal-title":"Diagnostic Cytopathol"},{"key":"10.1074\/mcp.M116.063511_bib47","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/ng.2468","article-title":"The genetic landscape of mutations in Burkitt lymphoma","volume":"44","author":"Love","year":"2012","journal-title":"Nat. Gen"},{"key":"10.1074\/mcp.M116.063511_bib48","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1073\/pnas.0901230107","article-title":"Induction of ectopic Myc target gene JAG2 augments hypoxic growth and tumorigenesis in a human B-cell model","volume":"107","author":"Yustein","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1074\/mcp.M116.063511_bib49","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/978-1-62703-269-8_17","article-title":"High-throughput RNA sequencing in B-cell lymphomas","volume":"971","author":"Xiao","year":"2013","journal-title":"Meth. Mol. Biol"},{"key":"10.1074\/mcp.M116.063511_bib50","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1128\/MCB.19.3.1720","article-title":"Correlation between protein and mRNA abundance in yeast","volume":"19","author":"Gygi","year":"1999","journal-title":"Mol. Cell. Biol"},{"key":"10.1074\/mcp.M116.063511_bib51","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrg3185","article-title":"Insights into the regulation of protein abundance from proteomic and transcriptomic analyses","volume":"13","author":"Vogel","year":"2012","journal-title":"Nat. Rev. Genet"},{"key":"10.1074\/mcp.M116.063511_bib52","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature10098","article-title":"Global quantification of mammalian gene expression control","volume":"473","author":"Schwanhausser","year":"2011","journal-title":"Nature"},{"key":"10.1074\/mcp.M116.063511_bib53","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1016\/j.transproceed.2010.07.022","article-title":"Definition of a target for immunotherapy and results of the first Peptide vaccination study in chronic lymphocytic leukemia","volume":"42","author":"Tabarkiewicz","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1074\/mcp.M116.063511_bib54","first-page":"210","article-title":"MHC class I antigen expression is inversely related with tumor malignancy and ras oncogene product (p21ras) levels in human breast tumors","volume":"12","author":"Solana","year":"1992","journal-title":"Invasion Metastasis"},{"key":"10.1074\/mcp.M116.063511_bib55","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1158\/2326-6066.CIR-14-0005","article-title":"Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma","volume":"2","author":"Paulson","year":"2014","journal-title":"Cancer Immunol. Res"},{"key":"10.1074\/mcp.M116.063511_bib56","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1126\/science.1083558","article-title":"Induction of tumors in mice by genomic hypomethylation","volume":"300","author":"Gaudet","year":"2003","journal-title":"Science"},{"key":"10.1074\/mcp.M116.063511_bib57","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3390\/genes6041076","article-title":"Epigenetic heterogeneity of B-Cell lymphoma: chromatin modifiers","volume":"6","author":"Hopp","year":"2015","journal-title":"Genes"},{"key":"10.1074\/mcp.M116.063511_bib58","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/nm.4125","article-title":"Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia","volume":"22","author":"Li","year":"2016","journal-title":"Nat. Med"},{"key":"10.1074\/mcp.M116.063511_bib59","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0092-8674(03)00120-X","article-title":"Cellular motility driven by assembly and disassembly of actin filaments","volume":"112","author":"Pollard","year":"2003","journal-title":"Cell"},{"key":"10.1074\/mcp.M116.063511_bib60","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1126\/science.1130563","article-title":"Requirement for coronin 1 in T lymphocyte trafficking and cellular homeostasis","volume":"313","author":"Foger","year":"2006","journal-title":"Science"},{"key":"10.1074\/mcp.M116.063511_bib61","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.immuni.2007.11.023","article-title":"The lupus-related Lmb3 locus contains a disease-suppressing Coronin-1A gene mutation","volume":"28","author":"Haraldsson","year":"2008","journal-title":"Immunity"},{"key":"10.1074\/mcp.M116.063511_bib62","doi-asserted-by":"crossref","first-page":"e9210","DOI":"10.1371\/journal.pone.0009210","article-title":"Quantitative kinetic study of the actin-bundling protein L-plastin and of its impact on actin turn-over","volume":"5","author":"Al Tanoury","year":"2010","journal-title":"PLoS One"},{"key":"10.1074\/mcp.M116.063511_bib63","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.4049\/jimmunol.1101033","article-title":"The actin-bundling protein L-plastin is essential for marginal zone B cell development","volume":"187","author":"Todd","year":"2011","journal-title":"J. Immunol"},{"key":"10.1074\/mcp.M116.063511_bib64","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/eji.201242780","article-title":"Intrinsic T- and B-cell defects impair T-cell-dependent antibody responses in mice lacking the actin-bundling protein L-plastin","volume":"43","author":"Todd","year":"2013","journal-title":"Eur. J. Immunol"},{"key":"10.1074\/mcp.M116.063511_bib65","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.1128\/IAI.71.11.6582-6590.2003","article-title":"CapG(-\/-) mice have specific host defense defects that render them more susceptible than CapG(+\/+) mice to Listeria monocytogenes infection but not to Salmonella enterica serovar Typhimurium infection","volume":"71","author":"Parikh","year":"2003","journal-title":"Infect. Immun"},{"key":"10.1074\/mcp.M116.063511_bib66","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1002\/ijc.21593","article-title":"The leukocyte protein L-plastin induces proliferation, invasion and loss of E-cadherin expression in colon cancer cells","volume":"118","author":"Foran","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1074\/mcp.M116.063511_bib67","doi-asserted-by":"crossref","first-page":"379847","DOI":"10.1155\/2014\/379847","article-title":"Macrophage capping protein CapG is a putative oncogene involved in migration and invasiveness in ovarian carcinoma","volume":"2014","author":"Glaser","year":"2014","journal-title":"Biomed. Res. Int"},{"key":"10.1074\/mcp.M116.063511_bib68","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1158\/0008-5472.CAN-09-4439","article-title":"Pseudopodial actin dynamics control epithelial-mesenchymal transition in metastatic cancer cells","volume":"70","author":"Shankar","year":"2010","journal-title":"Cancer Res"},{"key":"10.1074\/mcp.M116.063511_bib69","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1182\/blood-2011-11-394346","article-title":"Overexpression of TCL1 activates the endoplasmic reticulum stress response: a novel mechanism of leukemic progression in mice","volume":"120","author":"Kriss","year":"2012","journal-title":"Blood"},{"key":"10.1074\/mcp.M116.063511_bib70","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1182\/blood-2014-07-587790","article-title":"Two types of BCR interactions are positively selected during leukemia development in the Emu-TCL1 transgenic mouse model of CLL","volume":"125","author":"Iacovelli","year":"2015","journal-title":"Blood"},{"key":"10.1074\/mcp.M116.063511_bib71","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/272624a0","article-title":"Spontaneous murine B-cell leukaemia","volume":"272","author":"Slavin","year":"1978","journal-title":"Nature"},{"key":"10.1074\/mcp.M116.063511_bib72","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0008-8749(89)90279-7","article-title":"The BCL1 B lymphoma responds to IL-4, IL-5, and GM-CSF","volume":"123","author":"O'Garra","year":"1989","journal-title":"Cell Immunol"},{"key":"10.1074\/mcp.M116.063511_bib73","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/eji.1830190726","article-title":"Suppressive effect of interferon-gamma on the BCL1 cell-dependent interleukin 5 bioassay","volume":"19","author":"Lohoff","year":"1989","journal-title":"Eur. J. Immunol"},{"key":"10.1074\/mcp.M116.063511_bib74","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/eji.1830190222","article-title":"Characterization and growth factor requirements of SJL lymphomas. II. Interleukin 5 dependence of the in vitro cell line, cRCS-X, and influence of other cytokines","volume":"19","author":"Lasky","year":"1989","journal-title":"Eur. J. Immunol"},{"key":"10.1074\/mcp.M116.063511_bib75","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/eji.200425267","article-title":"Transgene-mediated hyper-expression of IL-5 inhibits autoimmune disease but increases the risk of B cell chronic lymphocytic leukemia in a model of murine lupus","volume":"34","author":"Wen","year":"2004","journal-title":"Eur. J. Immunol"},{"key":"10.1074\/mcp.M116.063511_bib76","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1084\/jem.180.6.2101","article-title":"IL-5 receptor-mediated tyrosine phosphorylation of SH2\/SH3-containing proteins and activation of Bruton's tyrosine and Janus 2 kinases","volume":"180","author":"Sato","year":"1994","journal-title":"J. Exp. Med"},{"key":"10.1074\/mcp.M116.063511_bib77","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1182\/blood.V91.7.2547","article-title":"Analysis of signal transduction pathways in human eosinophils activated by chemoattractants and the T-helper 2-derived cytokines interleukin-4 and interleukin-5","volume":"91","author":"Coffer","year":"1998","journal-title":"Blood"},{"key":"10.1074\/mcp.M116.063511_bib78","doi-asserted-by":"crossref","first-page":"C623","DOI":"10.1152\/ajpcell.1998.275.3.C623","article-title":"The mechanism of IL-5 signal transduction","volume":"275","author":"Adachi","year":"1998","journal-title":"Am. J. Physiol"},{"key":"10.1074\/mcp.M116.063511_bib79","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/eji.1830190926","article-title":"Interleukin 5 regulation of peritoneal Ly-1 B lymphocyte proliferation, differentiation and autoantibody secretion","volume":"19","author":"Wetzel","year":"1989","journal-title":"Eur. J. Immunol"},{"key":"10.1074\/mcp.M116.063511_bib80","first-page":"23","article-title":"Interleukin-5: an eosinophil growth and activation factor","volume":"69","author":"Sanderson","year":"1988","journal-title":"Dev. Biol. Stand"},{"key":"10.1074\/mcp.M116.063511_bib81","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1074-7613(00)80294-0","article-title":"IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses","volume":"4","author":"Kopf","year":"1996","journal-title":"Immunity"},{"key":"10.1074\/mcp.M116.063511_bib82","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/eji.1830171210","article-title":"Recombinant human interleukin 5 is an eosinophil differentiation factor but has no activity in standard human B cell growth factor assays","volume":"17","author":"Clutterbuck","year":"1987","journal-title":"Eur. J. Immunol"},{"key":"10.1074\/mcp.M116.063511_bib83","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3109\/10428199609093434","article-title":"Modulation of apoptosis with cytokines in B-cell chronic lymphocytic leukaemia","volume":"21","author":"Mainou-Fowler","year":"1996","journal-title":"Leukemia Lymphoma"},{"key":"10.1074\/mcp.M116.063511_bib84","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1021\/pr100395s","article-title":"Serum degradome markers for the detection of breast cancer","volume":"9","author":"van Winden","year":"2010","journal-title":"J. Proteome Res"},{"key":"10.1074\/mcp.M116.063511_bib85","doi-asserted-by":"crossref","first-page":"417","DOI":"10.18388\/abp.2013_2002","article-title":"Pre-analytical-related variability influencing serum peptide profiles demonstrated in a mass spectrometry-based search for colorectal and prostate cancer biomarkers","volume":"60","author":"Karczmarski","year":"2013","journal-title":"Acta Biochim. Pol"},{"key":"10.1074\/mcp.M116.063511_bib86","doi-asserted-by":"crossref","first-page":"e111364","DOI":"10.1371\/journal.pone.0111364","article-title":"Identification of potential serum proteomic biomarkers for clear cell renal cell carcinoma","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS One"},{"key":"10.1074\/mcp.M116.063511_bib87","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.amjmed.2003.09.045","article-title":"Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome","volume":"116","author":"Davidson","year":"2004","journal-title":"Am. J. Med"},{"key":"10.1074\/mcp.M116.063511_bib88","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00277-003-0608-2","article-title":"Incidence of tumor lysis syndrome in children with advanced stage Burkitt's lymphoma\/leukemia before and after introduction of prophylactic use of urate oxidase","volume":"82","author":"Wossmann","year":"2003","journal-title":"Ann. Hematol"},{"key":"10.1074\/mcp.M116.063511_bib89","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11739-008-0099-1","article-title":"Acute tumor lysis syndrome after rituximab administration in Burkitt's lymphoma","volume":"3","author":"Otrock","year":"2008","journal-title":"Intern. Emerg. Med"},{"key":"10.1074\/mcp.M116.063511_bib90","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3389\/fimmu.2015.00201","article-title":"Interactions between hyaluronan and its receptors (CD44, RHAMM) Regulate the activities of inflammation and cancer","volume":"6","author":"Misra","year":"2015","journal-title":"Front. Immunol"},{"key":"10.1074\/mcp.M116.063511_bib91","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.mce.2016.05.007","article-title":"Fibronectin-1 expression is increased in aggressive thyroid cancer and favors the migration and invasion of cancer cells","volume":"431","author":"Sponziello","year":"2016","journal-title":"Mol. Cell. Endocrinol"},{"key":"10.1074\/mcp.M116.063511_bib92","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1007\/s10620-014-3137-z","article-title":"S100A6 as a potential serum prognostic biomarker and therapeutic target in gastric cancer","volume":"59","author":"Zhang","year":"2014","journal-title":"Dig. Dis. Sci"},{"key":"10.1074\/mcp.M116.063511_bib93","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2220\/biomedres.35.351","article-title":"Serum expression of S100A6 is a potential detection marker in patients with urothelial carcinoma in the urinary bladder","volume":"35","author":"Nishi","year":"2014","journal-title":"Biomed. Res"},{"key":"10.1074\/mcp.M116.063511_bib94","doi-asserted-by":"crossref","first-page":"e21800","DOI":"10.1371\/journal.pone.0021800","article-title":"REVIGO summarizes and visualizes long lists of gene ontology terms","volume":"6","author":"Supek","year":"2011","journal-title":"PLoS One"}],"container-title":["Molecular & Cellular Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947620324208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947620324208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/mcp.M116.063511","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:37:19Z","timestamp":1761525439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535947620324208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":94,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S1535947620324208"],"URL":"https:\/\/doi.org\/10.1074\/mcp.m116.063511","relation":{},"ISSN":["1535-9476"],"issn-type":[{"value":"1535-9476","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrated Cellular and Plasma Proteomics of Contrasting B-cell Cancers Reveals Common, Unique and Systemic Signatures","name":"articletitle","label":"Article Title"},{"value":"Molecular & Cellular Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/mcp.M116.063511","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}